I'm expecting that the upcoming trial results will determine the timeline for considering offers - if the PMS outcomes are replicated, then it would indicate with a deal of confidence, that NNZ-2591 would be beneficial for people with other disorders both within and without of the autism spectrum.
The timing of the AGM on 28th May would seem almost perfect - can't wait to attend.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.92 |
Change
-0.040(0.31%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $2.031M | 157.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 556 | $12.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.93 | 156 | 9 |
View Market Depth
| Last trade - 12.48pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |